High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial (Q34763977)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

Anuradha Ganesan

1

object named as

Anuradha Ganesan

1 reference

Europe PubMed Central

4 August 2017

Nancy F Crum-Cianflone

2

object named as

Nancy Crum-Cianflone

1 reference

Europe PubMed Central

4 August 2017

Frank Maldarelli

14

object named as

Frank Maldarelli

1 reference

Europe PubMed Central

4 August 2017

5

object named as

Catherine Rehm

1 reference

Europe PubMed Central

4 August 2017

13

object named as

Dean Follmann

1 reference

Europe PubMed Central

4 August 2017

author name string

Jeanette Higgins

3

1 reference

Europe PubMed Central

4 August 2017

Jing Qin

4

1 reference

Europe PubMed Central

4 August 2017

Julia Metcalf

6

1 reference

Europe PubMed Central

4 August 2017

Carolyn Brandt

7

1 reference

Europe PubMed Central

4 August 2017

Jean Vita

8

1 reference

Europe PubMed Central

4 August 2017

Catherine F Decker

9

1 reference

Europe PubMed Central

4 August 2017

Peter Sklar

10

1 reference

Europe PubMed Central

4 August 2017

Mary Bavaro

11

1 reference

Europe PubMed Central

4 August 2017

Sybil Tasker

12

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

15 February 2011

1 reference

Europe PubMed Central

4 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

4 August 2017

203

1 reference

Europe PubMed Central

4 August 2017

6

1 reference

Europe PubMed Central

4 August 2017

756-764

1 reference

Europe PubMed Central

4 August 2017

Immunologic and virologic events in early HIV infection predict subsequent rate of progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

The macrophage: the intersection between HIV infection and atherosclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Atorvastatin: pharmacological characteristics and lipid-lowering effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Anti-inflammatory effects of statins: clinical evidence and basic mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Statins could be used to control replication of some viruses, including HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Statins inhibit HIV-1 infection by down-regulating Rho activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Lymphocyte Function-Associated Antigen-1 Blockade by Statins: Molecular Basis and Biological Relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Plasma membrane rafts play a critical role in HIV-1 assembly and release

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Human immunodeficiency virus long terminal repeat responds to T-cell activation signals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

7 July 2018

Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Evaluation of the anti-HIV activity of statins

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3071124

26 October 2018

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIQ115

21 January 2018

Statins as a newly recognized type of immunomodulator

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of statins on HIV rebound and blips

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21325137

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIQ115

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34763977&oldid=2003591180"